BG99261A - Steroid glycosides for the treatment of hyperchlesterolemia - Google Patents

Steroid glycosides for the treatment of hyperchlesterolemia

Info

Publication number
BG99261A
BG99261A BG99261A BG9926194A BG99261A BG 99261 A BG99261 A BG 99261A BG 99261 A BG99261 A BG 99261A BG 9926194 A BG9926194 A BG 9926194A BG 99261 A BG99261 A BG 99261A
Authority
BG
Bulgaria
Prior art keywords
treatment
hyperchlesterolemia
steroid glycosides
steroid
glycosides
Prior art date
Application number
BG99261A
Other languages
Bulgarian (bg)
English (en)
Inventor
Michael Deninno
Peter Mccarthy
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of BG99261A publication Critical patent/BG99261A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BG99261A 1992-06-26 1994-12-13 Steroid glycosides for the treatment of hyperchlesterolemia BG99261A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90491492A 1992-06-26 1992-06-26
PCT/US1993/004092 WO1994000480A1 (en) 1992-06-26 1993-05-06 Steroidal glycosides for treating hypercholesterolemia

Publications (1)

Publication Number Publication Date
BG99261A true BG99261A (en) 1995-06-30

Family

ID=25419965

Family Applications (1)

Application Number Title Priority Date Filing Date
BG99261A BG99261A (en) 1992-06-26 1994-12-13 Steroid glycosides for the treatment of hyperchlesterolemia

Country Status (19)

Country Link
US (2) US5629295A (xx)
EP (4) EP0796864A2 (xx)
JP (2) JPH07504921A (xx)
KR (1) KR950702203A (xx)
CN (1) CN1085561A (xx)
AP (1) AP489A (xx)
AU (1) AU4226593A (xx)
BG (1) BG99261A (xx)
BR (1) BR9306619A (xx)
CA (1) CA2139104A1 (xx)
CZ (1) CZ331094A3 (xx)
HR (1) HRP930994A2 (xx)
IL (1) IL106055A0 (xx)
MX (1) MX9303826A (xx)
OA (1) OA10121A (xx)
RU (1) RU94046294A (xx)
SK (1) SK158394A3 (xx)
WO (1) WO1994000480A1 (xx)
YU (1) YU44793A (xx)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994000478A1 (en) * 1992-06-26 1994-01-06 Pfizer Inc. Steroidal beta-o-cellobioside heptaalkanoate process
CA2161239A1 (en) * 1993-04-28 1994-11-10 Douglas J.M. Allen Spirostanyl glycosidal crystalline monohydrate
US5502038A (en) * 1993-06-21 1996-03-26 Medical Research Foundation Of Oregon Cholesterol sequestrant glycosides that inhibit intestinal cholesterol absorption
ES2074006B1 (es) * 1993-07-05 1996-03-16 Pfizer Glicosidos esteroidales para tratar hipercolesterolemia.
FI96243C (fi) * 1993-10-26 1996-05-27 Ilmari Paakkinen Menetelmä ja laite rakeisten maamassojen ominaisuuksien mittaamiseksi
JPH09500906A (ja) * 1993-12-28 1997-01-28 ファイザー・インク． 血中コレステロール低下薬
EP0737203A1 (en) * 1993-12-28 1996-10-16 Pfizer Inc. Steroidal glycosides
FR2722690B1 (fr) * 1994-07-21 1996-10-25 Univ Montpellier Ii Compositions de saponines et/ou de leurs formes aglycones et leurs applications comme medicaments
PL318937A1 (en) * 1994-08-30 1997-07-21 Pfizer Spirostanyloglycoside crystals
MX9702175A (es) * 1994-09-20 1997-06-28 Pfizer Combinacion de un inhibidor de absorcion de colesterol y un inhibidor de sintesis de colesterol.
US6150336A (en) * 1995-05-29 2000-11-21 Pfizer Inc. Steroidal glycosides
US5698527A (en) * 1995-08-08 1997-12-16 Merck & Co., Inc. Steroidal glycosides as antihyperlipidemic agents
US5756470A (en) * 1996-10-29 1998-05-26 Schering Corporation Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
GB9923076D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
HUP0101693A3 (en) * 1998-03-26 2002-08-28 Phytopharm Plc Godmanchester Use of steroidal sapogenins and their derivatives for producing pharmaceutical compositions for the treatment of alzheimeirs disease
JP3370610B2 (ja) * 1998-08-21 2003-01-27 武田薬品工業株式会社 害虫防除剤
US20030060425A1 (en) * 1998-11-24 2003-03-27 Ahlem Clarence N. Immune modulation method using steroid compounds
GB9923078D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
US6343258B1 (en) 1999-08-13 2002-01-29 ALEXIS Brian Method for testing for readiness for harvesting of tribulus terrestris l. having high steroidal saponin content
GB9923077D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
CA2389670A1 (en) * 1999-11-01 2001-05-10 Forbes Medi-Tech Inc. Novel glycosides comprising pentose mono-, di-, tri-, or oligosaccharides and phytosterols and/or phytostanols
GB0000228D0 (en) * 2000-01-06 2000-03-01 Phytopharm Plc Fluoro substituted sapogenins and their use
US6207638B1 (en) 2000-02-23 2001-03-27 Pacifichealth Laboratories, Inc. Nutritional intervention composition for enhancing and extending satiety
US6558690B2 (en) 2000-12-15 2003-05-06 Pacific Health Laboratories, Inc. Nutritional composition for improving the efficacy of a lipase inhibitor
US6429190B1 (en) 2000-12-15 2002-08-06 Pacifichealth Laboratories, Inc. Method for extending the satiety of food by adding a nutritional composition designed to stimulate cholecystokinin(CCK)
GB0107822D0 (en) * 2001-03-28 2001-05-23 Phytopharm Plc Sapogenin derivatives their synthesis and use methods based upon their use
US6703530B2 (en) * 2002-02-28 2004-03-09 General Electric Company Chemical reactor system and process
CN102727501A (zh) * 2002-03-27 2012-10-17 菲特法姆股份有限公司 皂角苷配基及其衍生物的用途
US20050130948A1 (en) * 2002-03-27 2005-06-16 Daryl Rees Therapeutic methods and uses of sapogenins and their derivatives
ATE459636T1 (de) * 2002-10-28 2010-03-15 Phytopharm Plc Stereospezifische reduktion von sapogen-3-onen
EP1819681B1 (en) 2004-11-23 2009-08-12 Warner-Lambert Company LLC 7-(2h-pyrazol-3-yl)-3,5-dihydroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for the treatment of lipidemia
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
CN101663262B (zh) 2006-12-01 2014-03-26 百时美施贵宝公司 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
JP5564490B2 (ja) 2008-04-18 2014-07-30 リアタ ファーマシューティカルズ インコーポレイテッド 抗炎症性ファルマコアを含む化合物および使用法
CA2731650A1 (en) 2008-07-22 2010-01-28 Tadashi Honda Monocyclic cyanoenones and methods of use thereof
US20130072519A1 (en) 2010-05-21 2013-03-21 Edward Lee Conn 2-phenyl benzoylamides
JP2014513923A (ja) 2011-03-04 2014-06-19 ファイザー・インク Ｅｄｎ３様ペプチドおよびその使用
CU20110244A7 (es) * 2011-12-27 2013-08-29 Ct De Investigación Y Desarrollo De Medicamentos Cidem Sistemas espiroesteroidales con efectos neuroactivos y anti-inflamatorios
MX2015014666A (es) 2013-04-17 2016-03-01 Pfizer Derivados de n-piperidin-3-ilbenzamida para tratar enfermedades cardiovasculares.
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
EP3911648A4 (en) 2019-01-18 2022-10-26 Astrazeneca AB PCSK9 INHIBITORS AND METHODS OF USE THEREOF

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3178418A (en) 1963-02-26 1965-04-13 Glaxo Lab Ltd Monobromination at the 11-position of hecogenin and 3-lower alkanoyl esters thereof
DE2926463A1 (de) * 1978-07-05 1980-01-24 Roecar Holdings Nv Spiroketaline und ihre verwendung
US4260603A (en) 1979-01-02 1981-04-07 Pegel Karl H Sterol glycoside with activity as prostaglandin synthetase inhibitor
NZ193564A (en) * 1979-05-02 1985-01-31 Aruba Pty Ltd Steroid alkaloids from solanum sodomeum and pharmaceutical compositions
US4602003A (en) 1982-05-17 1986-07-22 Medical Research Foundation Of Oregon Synthetic compounds to inhibit intestinal absorption of cholesterol in the treatment of hypercholesterolemia
US4602005A (en) 1982-05-17 1986-07-22 Medical Research Foundation Of Oregon Tigogenin cellobioside for treating hypercholesterolemia and atherosclerosis
ES524614A0 (es) * 1982-08-12 1984-05-01 Nativelle Sa Ets Procedimiento de preparacion de nuevos amino-14 esteroides.
ES524796A0 (es) * 1982-08-20 1984-05-01 Nativelle Sa Ets Procedimiento de preparacion de nuevos derivos de amino-14 esteroides
IT1188184B (it) 1985-08-14 1988-01-07 Texcontor Ets Sali ammonici quaternari di polisaccaridi ad attivita' ipocolesterolemizzante
US5017562A (en) * 1987-02-11 1991-05-21 Regents Of The University Of Minnesota Crystalline saponin-containing complex
FR2621316B1 (fr) * 1987-10-02 1991-06-21 Nativelle Sa Ets Nouveaux esters d'acide androstane 17-carboxylique, procede pour leur preparation, et medicament les contenant
US5010185A (en) * 1989-06-13 1991-04-23 Pfizer Inc. Processes for tigogenin beta-cellobioside
DE69222532T2 (de) * 1991-07-23 1998-02-26 Schering Corp Substituierte beta-lactam-verbindungen als hypocholesterolemische mittel und verfahren zu deren herstellung
WO1993005790A1 (en) * 1991-09-27 1993-04-01 Procter & Gamble Pharmaceuticals, Inc. Use of 14-aminosteroids for the manufacture of a medicament to slow the rate of progression of myocardial structural damages characteristic of congestive heart failure
WO1993007167A1 (en) * 1991-10-04 1993-04-15 The Procter & Gamble Company Cholesterol lowering compounds and process for making them
AU659506B2 (en) * 1991-11-25 1995-05-18 Pfizer Inc. Method for making steroidal peracyl glycosides
US5530107A (en) * 1992-10-15 1996-06-25 Pfizer Inc. Method for making steroidal peracyl glycosides
LT3595B (en) * 1993-01-21 1995-12-27 Schering Corp Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents

Also Published As

Publication number Publication date
CN1085561A (zh) 1994-04-20
HRP930994A2 (en) 1996-08-31
AP489A (en) 1996-05-02
EP0647234A1 (en) 1995-04-12
EP0796863A2 (en) 1997-09-24
KR950702203A (ko) 1995-06-19
WO1994000480A1 (en) 1994-01-06
AP9300539A0 (en) 1993-07-31
BR9306619A (pt) 1998-12-08
JPH09309897A (ja) 1997-12-02
RU94046294A (ru) 1996-10-10
YU44793A (xx) 1996-10-09
MX9303826A (es) 1994-02-28
AU4226593A (en) 1994-01-24
EP0796862A2 (en) 1997-09-24
US5703052A (en) 1997-12-30
IL106055A0 (en) 1993-10-20
CZ331094A3 (en) 1995-09-13
SK158394A3 (en) 1995-05-10
OA10121A (en) 1996-12-18
CA2139104A1 (en) 1994-01-06
US5629295A (en) 1997-05-13
EP0796864A2 (en) 1997-09-24
JPH07504921A (ja) 1995-06-01

Similar Documents

Publication Publication Date Title
BG99261A (en) Steroid glycosides for the treatment of hyperchlesterolemia
BG104247A (en) Resorcinol derivatives
EE9900481A (et) Väikesed molekulid, mida kasutatakse põletikuliste haiguste raviks
UA34466C2 (uk) Засіб для несистемної боротьби з паразитуючими комахами
TR199901174T2 (xx) Yeni heterosiklilmetil-ikameli pirazol t�revleri.
ATE255589T1 (de) Kristallin form i von clarithromycin
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
DK0973735T3 (da) Polyaromatiske antivirale præparater
DE69612003D1 (de) Substituierte benzolaktamverbindungen als substanz-p-antagonisten
NO965516D0 (no) Sterolderivater anvendt til regulering av meiose
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
ATE203519T1 (de) Chinolinderivate als antimalariamittel
DE69405919T2 (de) Zusammensetzungen zur Behandlung von Keratinfasern
MX9101958A (es) Inhibidores de acat de urea de aminosulfonilo
NO980296D0 (no) Forbedrede terapeutiske midler
DE69613395T2 (de) Schwefelenthaltende di-ter-butylphenol-verbindungen brauchbar als entzündungshemmende mittel
ATE160573T1 (de) 1,3.5 (10) - estratriene derivate mit oraler wirkung
MD960168A (ro) Metodă şi compuşi pentru tratamentul infecţiilor virale
NO962221L (no) Anvendelse av dimeticon for behandling av konstipasjon
ATE267209T1 (de) Reinigung von carboxaldehyd
PT751775E (pt) Derivados de mercaptoacetilamida hipocolesterolemicos, antiateroscleroticos e hipotrigliceridemicos
ITRM920305A1 (it) Composizione farmaceutica per il trattamento dello shock, particolarmente dello shock cardiogeno e dello shock settico.
GR1001368B (el) Φαρμακευτικοί φορείς.
DE69428127D1 (de) Schädlingsbekämpfungsmittel